1.212
Finanzdaten der Bone Biologics Corp-Aktie (BBLG)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
2.49%
0.7331
|
0.7153 | 0.7481 | 1.0385 | 1.5549 |
| Operating Income/Loss |
2.49%
-0.7331
|
-0.7153 | -0.7481 | -1.0385 | -1.5549 |
| Nonoperating Income/Loss |
0.15%
0.0485
|
0.0485 | 0.00756 | 0.0214 | 0.0332 |
| Income/Loss From Continuing Operations Before Tax |
4.99%
-0.70
|
-0.6667 | -0.7405 | -1.0171 | -1.5217 |
| Income/Loss From Continuing Operations After Tax |
4.99%
-0.70
|
-0.6667 | -0.7405 | -1.0171 | -1.5217 |
|
|
4.99%
-0.70
|
-0.6667 | -0.7405 | -1.0171 | -1.5217 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-0.0154
|
- | - | - | - |
| Basic Average Shares |
88.35%
0.2091
|
1.7951 | 0.5578 | 3.1832 | 0.3209 |
| Diluted Average Shares |
88.35%
0.2091
|
1.7951 | 0.5578 | 3.1832 | 0.3209 |
| Basic Earnings Per Share |
62.16%
-0.14
|
-0.37 | -1.33 | -0.32 | 0.02 |
| Diluted Earnings Per Share |
62.16%
-0.14
|
-0.37 | -1.33 | -0.32 | 0.02 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):